TRAW Stock Catalyst: Traws Pharma Announces Plans to Advance Hantavirus Treatment Candidates

May 7, 2026 · 3:59pm ET

Company to progress potential clinical candidates for Hantavirus infection.

Max move

+52.7%

High of day $2.58

Sparker timei

3:59pm ET

TRAW · May 7, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Traws Pharma, Inc. (Nasdaq: TRAW) announced plans to advance potential clinical candidates for the treatment of Hantavirus infection. The company revealed its intention to progress these candidates through further development stages.

No financial amounts or share considerations were disclosed in the announcement. The company's free float stands at 4,825,000 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time TRAW sparks.

Download Sniper App →

Catch the next TRAW-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →